Cell-based Assays Market Size, Share, and Trends 2024 to 2034

The global cell-based assays market size is calculated at USD 19.78 billion in 2025 and is forecasted to reach around USD 41.40 billion by 2034, accelerating at a CAGR of 8.54% from 2025 to 2034. The North America cell-based assays market size surpassed USD 7.85 billion in 2024 and is expanding at a CAGR of 8.57% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 2982
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cell-based Assays Market 

5.1. COVID-19 Landscape: Cell-based Assays Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cell-based Assays Market, By Type

8.1. Cell-based Assays Market, by Type

8.1.1. Cell Viability Assay

8.1.1.1. Market Revenue and Forecast

8.1.2. Cytotoxicity Assay

8.1.2.1. Market Revenue and Forecast

8.1.3. Cell Death Assay

8.1.3.1. Market Revenue and Forecast

8.1.4. Cell Proliferation Assay

8.1.4.1. Market Revenue and Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Cell-based Assays Market, By Products & Services

9.1. Cell-based Assays Market, by Products & Services

9.1.1. Reagents

9.1.1.1. Market Revenue and Forecast

9.1.2. Assay Kits

9.1.2.1. Market Revenue and Forecast

9.1.3. Microplates

9.1.3.1. Market Revenue and Forecast

9.1.4. Probes & Labels

9.1.4.1. Market Revenue and Forecast

9.1.5. Instruments & Software

9.1.5.1. Market Revenue and Forecast

9.1.6. Cell Lines

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Cell-based Assays Market, By Application 

10.1. Cell-based Assays Market, by Application

10.1.1. Basic Research

10.1.1.1. Market Revenue and Forecast

10.1.2. Drug Discovery

10.1.2.1. Market Revenue and Forecast

10.1.3. Other Applications

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Cell-based Assays Market, By Technology

11.1. Cell-based Assays Market, by Technology

11.1.1. Automated Handling

11.1.1.1. Market Revenue and Forecast

11.1.2. Flow Cytometry

11.1.2.1. Market Revenue and Forecast

11.1.3. Label-free Detection

11.1.3.1. Market Revenue and Forecast

11.1.4. High-throughput Screening

11.1.4.1. Market Revenue and Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Cell-based Assays Market, By End-use

12.1. Cell-based Assays Market, by End-use

12.1.1. Pharmaceutical and Biotechnology Companies

12.1.1.1. Market Revenue and Forecast

12.1.2. Academic & Government Institutes

12.1.2.1. Market Revenue and Forecast

12.1.3. Contract Research Organizations

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Cell-based Assays Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type

13.1.2. Market Revenue and Forecast, by Products & Services

13.1.3. Market Revenue and Forecast, by Application

13.1.4. Market Revenue and Forecast, by Technology

13.1.5. Market Revenue and Forecast, by End-use

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type

13.1.6.2. Market Revenue and Forecast, by Products & Services

13.1.6.3. Market Revenue and Forecast, by Application

13.1.6.4. Market Revenue and Forecast, by Technology

13.1.6.5. Market Revenue and Forecast, by End-use  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type

13.1.7.2. Market Revenue and Forecast, by Products & Services

13.1.7.3. Market Revenue and Forecast, by Application

13.1.7.4. Market Revenue and Forecast, by Technology

13.1.7.5. Market Revenue and Forecast, by End-use

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type

13.2.2. Market Revenue and Forecast, by Products & Services

13.2.3. Market Revenue and Forecast, by Application

13.2.4. Market Revenue and Forecast, by Technology  

13.2.5. Market Revenue and Forecast, by End-use  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type

13.2.6.2. Market Revenue and Forecast, by Products & Services

13.2.6.3. Market Revenue and Forecast, by Application

13.2.7. Market Revenue and Forecast, by Technology  

13.2.8. Market Revenue and Forecast, by End-use  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type

13.2.9.2. Market Revenue and Forecast, by Products & Services

13.2.9.3. Market Revenue and Forecast, by Application

13.2.10. Market Revenue and Forecast, by Technology

13.2.11. Market Revenue and Forecast, by End-use

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type

13.2.12.2. Market Revenue and Forecast, by Products & Services

13.2.12.3. Market Revenue and Forecast, by Application

13.2.12.4. Market Revenue and Forecast, by Technology

13.2.13. Market Revenue and Forecast, by End-use

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type

13.2.14.2. Market Revenue and Forecast, by Products & Services

13.2.14.3. Market Revenue and Forecast, by Application

13.2.14.4. Market Revenue and Forecast, by Technology

13.2.15. Market Revenue and Forecast, by End-use

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type

13.3.2. Market Revenue and Forecast, by Products & Services

13.3.3. Market Revenue and Forecast, by Application

13.3.4. Market Revenue and Forecast, by Technology

13.3.5. Market Revenue and Forecast, by End-use

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type

13.3.6.2. Market Revenue and Forecast, by Products & Services

13.3.6.3. Market Revenue and Forecast, by Application

13.3.6.4. Market Revenue and Forecast, by Technology

13.3.7. Market Revenue and Forecast, by End-use

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type

13.3.8.2. Market Revenue and Forecast, by Products & Services

13.3.8.3. Market Revenue and Forecast, by Application

13.3.8.4. Market Revenue and Forecast, by Technology

13.3.9. Market Revenue and Forecast, by End-use

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type

13.3.10.2. Market Revenue and Forecast, by Products & Services

13.3.10.3. Market Revenue and Forecast, by Application

13.3.10.4. Market Revenue and Forecast, by Technology

13.3.10.5. Market Revenue and Forecast, by End-use

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type

13.3.11.2. Market Revenue and Forecast, by Products & Services

13.3.11.3. Market Revenue and Forecast, by Application

13.3.11.4. Market Revenue and Forecast, by Technology

13.3.11.5. Market Revenue and Forecast, by End-use

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type

13.4.2. Market Revenue and Forecast, by Products & Services

13.4.3. Market Revenue and Forecast, by Application

13.4.4. Market Revenue and Forecast, by Technology

13.4.5. Market Revenue and Forecast, by End-use

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type

13.4.6.2. Market Revenue and Forecast, by Products & Services

13.4.6.3. Market Revenue and Forecast, by Application

13.4.6.4. Market Revenue and Forecast, by Technology

13.4.7. Market Revenue and Forecast, by End-use

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type

13.4.8.2. Market Revenue and Forecast, by Products & Services

13.4.8.3. Market Revenue and Forecast, by Application

13.4.8.4. Market Revenue and Forecast, by Technology

13.4.9. Market Revenue and Forecast, by End-use

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type

13.4.10.2. Market Revenue and Forecast, by Products & Services

13.4.10.3. Market Revenue and Forecast, by Application

13.4.10.4. Market Revenue and Forecast, by Technology

13.4.10.5. Market Revenue and Forecast, by End-use

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type

13.4.11.2. Market Revenue and Forecast, by Products & Services

13.4.11.3. Market Revenue and Forecast, by Application

13.4.11.4. Market Revenue and Forecast, by Technology

13.4.11.5. Market Revenue and Forecast, by End-use

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type

13.5.2. Market Revenue and Forecast, by Products & Services

13.5.3. Market Revenue and Forecast, by Application

13.5.4. Market Revenue and Forecast, by Technology

13.5.5. Market Revenue and Forecast, by End-use

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type

13.5.6.2. Market Revenue and Forecast, by Products & Services

13.5.6.3. Market Revenue and Forecast, by Application

13.5.6.4. Market Revenue and Forecast, by Technology

13.5.7. Market Revenue and Forecast, by End-use

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type

13.5.8.2. Market Revenue and Forecast, by Products & Services

13.5.8.3. Market Revenue and Forecast, by Application

13.5.8.4. Market Revenue and Forecast, by Technology

13.5.8.5. Market Revenue and Forecast, by End-use

Chapter 14. Company Profiles

14.1. Danaher Corporation

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Lonza Group AG

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Promega Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. F. Hoffmann-La Roche AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Charles River Laboratories International, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Menarini Silicon Biosystems, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bio-Rad Laboratories, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Macrogen Inc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. DiscoverX Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global cell-based assays market size is expected to reach around USD 41.40 billion by 2034 from USD 18.25 billion in 2024.

The global cell-based assays market will register growth rate of 8.54% between 2025 and 2034.

The major players operating in the cell-based assays market are Danaher Corporation, Lonza Group AG, Promega Corporation, F. Hoffmann-La Roche AG, Charles River Laboratories International, Inc., Menarini Silicon Biosystems, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Macrogen Inc, DiscoverX Corporation, Corning Inc., Merck KGaA, Thermo Fisher Scientific Inc., Perkinelmer, Inc., Biognosys, Cell Signaling Technology, Inc., Lebermuth, Inc., Eurofins DiscoverX Products, and Others.

The driving factors of the cell-based assays market are the growing emphasis on personalized medicine, rising government investments in research and developments, and expansion of pharmaceutical and biotechnology industries.

North America region will lead the global cell-based assays market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client